{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:51:33Z","timestamp":1794462693445,"version":"4.9.1"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154819"],"award-info":[{"award-number":["1154819"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cyto.2021.155655","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T06:19:35Z","timestamp":1627453175000},"page":"155655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Influences of the IL-6 cytokine family on bone structure and function"],"prefix":"10.1016","volume":"146","author":[{"given":"Natalie A.","family":"Sims","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 Is a Critical Inhibitor of Interferon \u03b3 Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0015","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V89.9.3148","article-title":"CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation","volume":"89","author":"Matsumoto","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","article-title":"Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation","volume":"11","author":"Kotake","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.21537","article-title":"Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis","volume":"54","author":"Wong","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0030","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2141.1996.4721018.x","article-title":"Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma","volume":"93","author":"Kyrtsonis","year":"1996","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/gut.36.1.45","article-title":"Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6","volume":"36","author":"Mitsuyama","year":"1995","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0040","first-page":"1893","article-title":"Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease","volume":"81","author":"Devlin","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.cyto.2021.155655_b0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"21","key":"10.1016\/j.cyto.2021.155655_b0050","article-title":"Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications. JCI","volume":"2","author":"Torossian","year":"2017","journal-title":"Insight"},{"issue":"8","key":"10.1016\/j.cyto.2021.155655_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0714.2007.00553.x","article-title":"Cranial suture biology and dental development: genetic and clinical perspectives","volume":"36","author":"De Coster","year":"2007","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.cyto.2021.155655_b0060","article-title":"The Cells of Bone and Their Interactions","author":"Ansari","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0065","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI10753","article-title":"Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5","volume":"106","author":"Sims","year":"2000","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jbmr.359","article-title":"IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP\/Ihh pathway","volume":"26","author":"Wang","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1101\/gad.8.3.277","article-title":"Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene","volume":"8","author":"Karaplis","year":"1994","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/JOE-11-0048","article-title":"The skeleton: a multi-functional complex organ. The growth plate chondrocyte and endochondral ossification","volume":"211","author":"Mackie","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cyto.2021.155655_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-021-03884-w","article-title":"Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes","author":"Isojima","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00223-013-9790-y","article-title":"Osteocytes: master orchestrators of bone","volume":"94","author":"Schaffler","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cyto.2021.155655_b0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-021119-034425","article-title":"Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms","volume":"82","author":"Sims","year":"2020","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11154-014-9308-6","article-title":"RANKL\/OPG; Critical role in bone physiology","volume":"16","author":"Martin","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00223-012-9600-y","article-title":"Osteoclast fusion and fission","volume":"90","author":"Jansen","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"McDonald","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155655_b0115","series-title":"Skeletal stem cells: tissue-specific stem\/progenitor cells of cartilage, bone, stroma, and marrow adipocytes, in Principles of Bone Biology","first-page":"45","author":"Gehron Robey","year":"2020"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/joe.0.1700451","article-title":"Changing RANKL\/OPG mRNA expression in differentiating murine primary osteoblasts","volume":"170","author":"Thomas","year":"2001","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S8756-3282(98)00092-1","article-title":"Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin","volume":"23","author":"Boskey","year":"1998","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008586","article-title":"Osteocalcin is necessary for the alignment of apatite crystallites, but not glucose metabolism, testosterone synthesis, or muscle mass","volume":"16","author":"Moriishi","year":"2020","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008361","article-title":"An osteocalcin-deficient mouse strain without endocrine abnormalities","volume":"16","author":"Diegel","year":"2020","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI119276","article-title":"Pex\/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice","volume":"99","author":"Beck","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2021.155655_b0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bone.2015.02.016","article-title":"Quantifying the osteocyte network in the human skeleton","volume":"75","author":"Buenzli","year":"2015","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cyto.2021.155655_b0155","doi-asserted-by":"crossref","DOI":"10.1007\/s11914-019-00524-y","article-title":"Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown","author":"Blank","year":"2019","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0160","first-page":"292","article-title":"Physiological and pathological osteocytic osteolysis","volume":"18","author":"Tsourdi","year":"2018","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"13","key":"10.1016\/j.cyto.2021.155655_b0165","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","article-title":"Bone as an endocrine organ","volume":"20","author":"Fukumoto","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002239900715","article-title":"Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1\u201334","volume":"65","author":"Liang","year":"1999","journal-title":"Calcif. Tissue Int."},{"issue":"10","key":"10.1016\/j.cyto.2021.155655_b0180","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0185","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.180.11.7102","article-title":"Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells","volume":"180","author":"Briso","year":"2008","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0190","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119821","article-title":"Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha","volume":"100","author":"Modur","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0195","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jbmr.5650040422","article-title":"Interleukin-6 is produced by bone and modulated by parathyroid hormone","volume":"4","author":"Feyen","year":"1989","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0200","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0006-291X(89)90851-6","article-title":"Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis","volume":"162","author":"Lowik","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0205","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/endo-129-3-1513","article-title":"The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro","volume":"129","author":"Littlewood","year":"1991","journal-title":"Endocrinology"},{"issue":"24","key":"10.1016\/j.cyto.2021.155655_b0210","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S8756-3282(98)00040-4","article-title":"Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation","volume":"22","author":"Gao","year":"1998","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0220","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2021.155655_b0225","doi-asserted-by":"crossref","first-page":"41411","DOI":"10.1038\/srep41411","article-title":"Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-kappaB, ERK and JNK signaling pathways","volume":"7","author":"Feng","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0230","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","article-title":"Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system","volume":"54","author":"De Benedetti","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0235","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion","volume":"13","author":"Poli","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2021.155655_b0240","article-title":"Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities","author":"Scheller","year":"2013","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0245","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2265.1999.00896.x","article-title":"Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro","volume":"51","author":"Girasole","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0250","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.4049\/jimmunol.1002015","article-title":"Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity","volume":"185","author":"Lissilaa","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0255","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajpath.2017.10.011","article-title":"Distinct Effects of IL-6 Classic and Trans-Signaling in Bone Fracture Healing","volume":"188","author":"Prystaz","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"5066","key":"10.1016\/j.cyto.2021.155655_b0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0265","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","article-title":"Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice","volume":"94","author":"Kitazawa","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2021.155655_b0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bone.2018.04.015","article-title":"IL-6 trans-signalling mediates trabecular, but not cortical, bone loss after ovariectomy","volume":"112","author":"Lazzaro","year":"2018","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0275","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI118432","article-title":"Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal\/osteoblastic cells","volume":"97","author":"Bellido","year":"1996","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0280","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/endo.138.9.5364","article-title":"Activation of the Janus kinase\/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation","volume":"138","author":"Bellido","year":"1997","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0285","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.1998.13.5.777","article-title":"Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells","volume":"13","author":"Nishimura","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cyto.2021.155655_b0290","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/bonekey.2014.66","article-title":"Osteocyte expression of caspase-3, COX-2, IL-6 and sclerostin are spatially and temporally associated following stress fracture initiation","volume":"3","author":"Wu","year":"2014","journal-title":"BoneKEy Reports"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0295","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jbmr.3027","article-title":"Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover","volume":"32","author":"Metzger","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0300","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0022034514522485","article-title":"IL-6 Alters Osteocyte Signaling toward Osteoblasts but Not Osteoclasts","volume":"93","author":"Bakker","year":"2014","journal-title":"J. Dent. Res."},{"issue":"19","key":"10.1016\/j.cyto.2021.155655_b0305","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1074\/jbc.RA119.008074","article-title":"IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis","volume":"294","author":"McGregor","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0310","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1359\/JBMR.050209","article-title":"Interleukin-11 receptor signaling is required for normal bone remodeling","volume":"20","author":"Sims","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cyto.2021.155655_b0315","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2015.08.005","article-title":"Glycoprotein130 (Gp130)\/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone","volume":"81","author":"Johnson","year":"2015","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0320","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.148.7.2175","article-title":"Human soluble IL-6 receptor: its detection and enhanced release by HIV infection","volume":"148","author":"Honda","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S8756-3282(99)00099-X","article-title":"Localization of ADAM10 and notch receptors in bone","volume":"25","author":"Dallas","year":"1999","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0330","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S8756-3282(99)00214-8","article-title":"Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues","volume":"25","author":"Kartsogiannis","year":"1999","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0335","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","article-title":"Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors","volume":"182","author":"Udagawa","year":"1995","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0340","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2007-07-102137","article-title":"Transgenic blockade of interleukin 6 transsignaling abrogates inflammation","volume":"111","author":"Rabe","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0345","first-page":"591","article-title":"The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options","volume":"102","author":"Rose-John","year":"2017","journal-title":"Inflammation."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0350","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004399900126","article-title":"Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis","volume":"105","author":"Ota","year":"1999","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0355","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s100380170077","article-title":"A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density","volume":"46","author":"Ota","year":"2001","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semarthrit.2012.01.004","article-title":"IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522)","volume":"42","author":"Karsdal","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0365","first-page":"921","article-title":"Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis","volume":"29","author":"Terpos","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0370","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","article-title":"Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways","volume":"113","author":"Sims","year":"2004","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0375","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbmr.5650090111","article-title":"Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in paget's disease","volume":"9","author":"Hoyland","year":"1994","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI115584","article-title":"Interleukin 6. A potential autocrine\/paracrine factor in Paget's disease of bone","volume":"89","author":"Roodman","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0385","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI114392","article-title":"Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias","volume":"84","author":"Bataille","year":"1989","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0390","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V74.1.11.11","article-title":"Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma","volume":"74","author":"Zhang","year":"1989","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.cyto.2021.155655_b0395","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/1078-0432.CCR-09-1483","article-title":"A High-Affinity Fully Human Anti\u2013IL-6 mAb, 1339, for the Treatment of Multiple Myeloma","volume":"15","author":"Fulciniti","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0400","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.144.2.499","article-title":"IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro","volume":"144","author":"Guerne","year":"1990","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0405","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1074\/jbc.M110773200","article-title":"JAK\/STAT but not ERK1\/ERK2 pathway mediates interleukin (IL)-6\/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression","volume":"278","author":"Legendre","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0410","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/annrheumdis-2016-209757","article-title":"Systemic inhibition of IL-6\/Stat3 signalling protects against experimental osteoarthritis","volume":"76","author":"Latourte","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2021.155655_b0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2014.05.015","article-title":"Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts","volume":"561","author":"Sims","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2018.09.005","article-title":"Mutations in Craniosynostosis Patients Cause Defective Interleukin-11 Receptor Maturation and Drive Craniosynostosis-like Disease in Mice","volume":"25","author":"Agthe","year":"2018","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0430","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mgg3.28","article-title":"Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis","volume":"1","author":"Keupp","year":"2013","journal-title":"Mol. Genet. Genomic Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0435","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41413-020-0098-z","article-title":"A variant in IL6ST with a selective IL-11 signaling defect in human and mouse","volume":"8","author":"Schwerd","year":"2020","journal-title":"Bone Res."},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0440","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/endo.139.11.6433","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0445","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2407-13-16","article-title":"IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells","volume":"13","author":"McCoy","year":"2013","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0450","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.183.6.2581","article-title":"The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures","volume":"183","author":"Romas","year":"1996","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0455","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jbmr.1506","article-title":"Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo","volume":"27","author":"Walker","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0460","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/107999001753124435","article-title":"Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1\/2 cells","volume":"21","author":"Suga","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0465","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J Clin Invest"},{"issue":"50","key":"10.1016\/j.cyto.2021.155655_b0470","doi-asserted-by":"crossref","first-page":"49011","DOI":"10.1074\/jbc.M207804200","article-title":"Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice","volume":"277","author":"Takeuchi","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0475","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jbmr.193","article-title":"Gene expression patterns in bone following mechanical loading","volume":"26","author":"Mantila Roosa","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0480","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bone.2009.07.087","article-title":"Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation","volume":"45","author":"Kido","year":"2009","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013090","article-title":"Mechanical stress activates Smad pathway through PKCdelta to enhance interleukin-11 gene transcription in osteoblasts","volume":"5","author":"Kido","year":"2010","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0490","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/79683","article-title":"Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis","volume":"6","author":"Sabatakos","year":"2000","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0495","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S8756-3282(01)00622-6","article-title":"Regulating DeltaFosB expression in adult tet-off-DeltaFosB transgenic mice alters bone formation and bone mass","volume":"30","author":"Sims","year":"2002","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0500","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.cyto.2021.155655_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115843","article-title":"Leukemia inhibitory factor treatment attenuates the detrimental effects of glucocorticoids on bone in mice","volume":"145","author":"Lee","year":"2021","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0510","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.celrep.2016.01.053","article-title":"Proteolytic Cleavage Governs Interleukin-11 Trans-signaling","volume":"14","author":"Lokau","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.cyto.2021.155655_b0515","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cytogfr.2021.04.002","article-title":"The cytokine interleukin-11 crucially links bone formation, remodeling and resorption","volume":"60","author":"Kespohl","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2021.155655_b0520","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93623-9","article-title":"Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis","volume":"11","author":"Ng","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0525","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jmedgenet-2016-104215","article-title":"Diagnostic value of exome and whole genome sequencing in craniosynostosis","volume":"54","author":"Miller","year":"2017","journal-title":"J. Med. Genet."},{"issue":"29","key":"10.1016\/j.cyto.2021.155655_b0530","doi-asserted-by":"crossref","first-page":"21527","DOI":"10.1016\/S0021-9258(20)80573-0","article-title":"Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases","volume":"268","author":"Maier","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0535","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.38701","article-title":"Key Role of Suppressor of Cytokine Signaling 3 in Regulating gp130 Cytokine-Induced Signaling and Limiting Chondrocyte Responses During Murine Inflammatory Arthritis","volume":"66","author":"Liu","year":"2014","journal-title":"Arthritis & Rheumatology"},{"issue":"24","key":"10.1016\/j.cyto.2021.155655_b0540","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0545","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2249.2000.01114.x","article-title":"Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M","volume":"119","author":"Lisignoli","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0550","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jcb.21245","article-title":"Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells","volume":"101","author":"Song","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0555","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1354\/vp.46-1-124","article-title":"Mice Overexpressing Murine Oncostatin M (OSM) Exhibit Changes in Hematopoietic and Other Organs that Are Distinct from Those of Mice Overexpressing Human OSM or Bovine OSM","volume":"46","author":"Juan","year":"2009","journal-title":"Vet. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0560","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcb.240540113","article-title":"Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein","volume":"54","author":"Gimble","year":"1994","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0565","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jbmr.2159","article-title":"The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation","volume":"29","author":"Johnson","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"51","key":"10.1016\/j.cyto.2021.155655_b0570","doi-asserted-by":"crossref","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","article-title":"Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation","volume":"271","author":"Mosley","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0575","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V90.1.165.165_165_173","article-title":"Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice","volume":"90","author":"Ichihara","year":"1997","journal-title":"Blood"},{"issue":"41","key":"10.1016\/j.cyto.2021.155655_b0580","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1074\/jbc.M116.748483","article-title":"Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass","volume":"291","author":"Walker","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073266","article-title":"Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner","volume":"8","author":"Fernandes","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039871","article-title":"Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation","volume":"7","author":"Nicolaidou","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0595","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/stem.1040","article-title":"Induction of osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling","volume":"30","author":"Guihard","year":"2012","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0600","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","article-title":"Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo","volume":"181","author":"Chang","year":"2008","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0605","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","article-title":"Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model","volume":"26","author":"Alexander","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0610","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.4519","article-title":"Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle","volume":"236","author":"Genet","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.cyto.2021.155655_b0615","article-title":"Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr 1(R206H) Mouse Model of Fibrodysplasia Ossificans Progressiva","author":"Convente","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cyto.2021.155655_b0620","article-title":"Macrophages driving heterotopic ossification: Convergence of genetically-driven and trauma-driven mechanisms","author":"Levesque","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0625","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.joca.2007.05.002","article-title":"Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M","volume":"16","author":"Durigova","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0630","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2434","article-title":"Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity","volume":"10","author":"Karsdal","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0635","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0002-9440(10)64634-2","article-title":"Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo","volume":"157","author":"Langdon","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0640","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)61120-0","article-title":"Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand","volume":"160","author":"de Hooge","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0645","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/endo-127-4-1602","article-title":"Leukemia inhibitory factor binds with high affinity to preosteoblastic RCT-1 cells and potentiates the retinoic acid induction of alkaline phosphatase","volume":"127","author":"Rodan","year":"1990","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0650","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jcp.1041450116","article-title":"Osteoblasts display receptors for and responses to leukemia-inhibitory factor","volume":"145","author":"Allan","year":"1990","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0655","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jcp.1041480315","article-title":"Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice","volume":"148","author":"Hilton","year":"1991","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0660","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/jbmr.5650101106","article-title":"Leukemia inhibitory factor as a mediator of JAK\/STAT activation in murine osteoblasts","volume":"10","author":"Lowe","year":"1995","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0665","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jbmr.1485","article-title":"Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization","volume":"27","author":"Poulton","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0670","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/dev.121.5.1283","article-title":"Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death","volume":"121","author":"Ware","year":"1995","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0675","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/en.2003-0839","article-title":"Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro","volume":"145","author":"Shin","year":"2004","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0680","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1210\/endo.138.11.5534","article-title":"Osteoclasts are present in gp130-deficient mice","volume":"138","author":"Kawasaki","year":"1997","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0685","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/cyto.1999.0635","article-title":"Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone","volume":"12","author":"Richards","year":"2000","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019665","article-title":"Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice","volume":"6","author":"Menkhorst","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0695","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/381715","article-title":"Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann\/Schwartz-Jampel type 2 syndrome","volume":"74","author":"Dagoneau","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.cyto.2021.155655_b0700","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s002470050464","article-title":"Presentation of six cases of Stuve-Wiedemann syndrome","volume":"28","author":"Cormier-Daire","year":"1998","journal-title":"Pediatr. Radiol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0705","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-0004.2009.01314.x","article-title":"Stuve-Wiedemann syndrome: long-term follow-up and genetic heterogeneity","volume":"77","author":"Jung","year":"2010","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0710","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0006-291X(86)90577-2","article-title":"Synthesis of colony-stimulating factor (CSF) and differentiation-inducing factor (D-factor) by osteoblastic cells, clone MC3T3-E1","volume":"134","author":"Shiina-Ishimi","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0715","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/cyto.2002.2002","article-title":"Leukaemia inhibitory factor (lif) is expressed in hypertrophic chondrocytes and vascular sprouts during osteogenesis","volume":"20","author":"Grimaud","year":"2002","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0720","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jcp.1041520110","article-title":"Leukemia inhibitory factor\/differentiation-stimulating factor (LIF\/D-factor): regulation of its production and possible roles in bone metabolism","volume":"152","author":"Ishimi","year":"1992","journal-title":"J. Cell. Physiol."},{"issue":"347","key":"10.1016\/j.cyto.2021.155655_b0725","article-title":"Osteoblast and Osteoclast Activity Affect Bone Remodeling Upon Regulation by Mechanical Loading-Induced Leukemia Inhibitory Factor Expression in Osteocytes","volume":"7","author":"Du","year":"2020","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/j.cyto.2021.155655_b0730","first-page":"77","article-title":"Leukaemia inhibitory factor\u2013an exercise-induced myokine","volume":"16","author":"Broholm","year":"2010","journal-title":"Exercise immunology review"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0735","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.04.001","article-title":"Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts","volume":"68","author":"Le Goff","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155655_b0740","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fimmu.2019.01164","article-title":"Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor","volume":"10","author":"Persson","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0745","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/endo.132.3.8440191","article-title":"The effect of leukemia inhibitory factor on bone in vivo","volume":"132","author":"Cornish","year":"1993","journal-title":"Endocrinology"},{"issue":"15","key":"10.1016\/j.cyto.2021.155655_b0750","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1073\/pnas.86.15.5948","article-title":"Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor","volume":"86","author":"Metcalf","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0755","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/endo-127-1-185","article-title":"Leukemia inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger ribonucleic acid level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3E1) cells","volume":"127","author":"Noda","year":"1990","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0760","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0006-291X(91)91604-B","article-title":"Murine recombinant leukemia inhibitory factor modulates inhibitory effect of 1,25 dihydroxyvitamin D3 on alkaline phosphatase activity in MC3T3-E1 cells","volume":"175","author":"Hakeda","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0765","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/endo.136.4.7895651","article-title":"Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures","volume":"136","author":"Malaval","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0770","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/08977194.2012.656760","article-title":"Leukemia inhibitory factor: a paracrine mediator of bone metabolism","volume":"30","author":"Sims","year":"2012","journal-title":"Growth Factors"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0775","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00223-010-9337-4","article-title":"Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling","volume":"86","author":"McGregor","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.cyto.2021.155655_b0780","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"7201","key":"10.1016\/j.cyto.2021.155655_b0785","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature07019","article-title":"Osteoclast size is controlled by Fra-2 through LIF\/LIF-receptor signalling and hypoxia","volume":"454","author":"Bozec","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0790","doi-asserted-by":"crossref","first-page":"H750","DOI":"10.1152\/ajpheart.00161.2007","article-title":"Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells","volume":"294","author":"Ichiki","year":"2008","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0795","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1165\/ajrcmb.20.4.3429","article-title":"Leukemia Inhibitory Factor (LIF) and LIF Receptor in Human Lung","volume":"20","author":"Knight","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0800","first-page":"361","article-title":"Expression of leukemia inhibitory factor is regulated in human mesenchymal cells","volume":"5","author":"Lubbert","year":"1991","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.cyto.2021.155655_b0805","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1074\/jbc.270.18.10915","article-title":"Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor\/gp130 signaling complex","volume":"270","author":"Pennica","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0810","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1074\/jbc.M110.178251","article-title":"Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment","volume":"286","author":"Quach","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cyto.2021.155655_b0815","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/jbmr.3175","article-title":"Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts","volume":"32","author":"Koide","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0820","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200701148","article-title":"Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-\/-) mice","volume":"178","author":"Gil-Henn","year":"2007","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0825","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ydbio.2010.06.018","article-title":"Severe developmental bone phenotype in ClC-7 deficient mice","volume":"344","author":"Neutzsky-Wulff","year":"2010","journal-title":"Dev. Biol."},{"issue":"44","key":"10.1016\/j.cyto.2021.155655_b0830","doi-asserted-by":"crossref","first-page":"30341","DOI":"10.1074\/jbc.M803239200","article-title":"Ciliary Neurotrophic Factor, Cardiotrophin-like Cytokine, and Neuropoietin Share a Conserved Binding Site on the Ciliary Neurotrophic Factor Receptor \u03b1 Chain","volume":"283","author":"Rousseau","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b0835","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/78765","article-title":"CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex","volume":"3","author":"Elson","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"14","key":"10.1016\/j.cyto.2021.155655_b0840","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1073\/pnas.0306178101","article-title":"Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor","volume":"101","author":"Derouet","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5102","key":"10.1016\/j.cyto.2021.155655_b0845","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1126\/science.7681218","article-title":"Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses","volume":"259","author":"Davis","year":"1993","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.cyto.2021.155655_b0850","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1128\/MCB.00274-10","article-title":"Sortilin facilitates signaling of ciliary neurotrophic factor and related helical type 1 cytokines targeting the gp130\/leukemia inhibitory factor receptor beta heterodimer","volume":"30","author":"Larsen","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cyto.2021.155655_b0855","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M710462200","article-title":"Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes","author":"White","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155655_b0860","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bone.2014.03.053","article-title":"Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation","volume":"64","author":"Johnson","year":"2014","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0865","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1097-4695(19991115)41:3<317::AID-NEU1>3.0.CO;2-X","article-title":"Effects of testosterone on the development of a sexually dimorphic neuromuscular system in ciliary neurotrophic factor receptor knockout mice","volume":"41","author":"Park","year":"1999","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.cyto.2021.155655_b0870","doi-asserted-by":"crossref","first-page":"15529","DOI":"10.1038\/srep15529","article-title":"Ciliary neurotrophic factor has intrinsic and extrinsic roles in regulating B cell differentiation and bone structure","volume":"5","author":"Askmyr","year":"2015","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.cyto.2021.155655_b0875","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1074\/jbc.M111.310581","article-title":"Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase\/activator protein-1","volume":"287","author":"Whitham","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155655_b0880","doi-asserted-by":"crossref","unstructured":"Broholm, C., et al., LIF is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol (1985), 2011. 111(1): p. 251-9.","DOI":"10.1152\/japplphysiol.01399.2010"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0885","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JES.0b013e318201f601","article-title":"A role for myokines in muscle-bone interactions","volume":"39","author":"Hamrick","year":"2011","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"20","key":"10.1016\/j.cyto.2021.155655_b0890","doi-asserted-by":"crossref","first-page":"11458","DOI":"10.1073\/pnas.96.20.11458","article-title":"Novel neurotrophin-1\/B cell-stimulating factor-3: a cytokine of the IL-6 family","volume":"96","author":"Senaldi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0895","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0960-9822(99)80266-8","article-title":"Suckling defect in mice lacking the soluble haemopoietin receptor NR6","volume":"9","author":"Alexander","year":"1999","journal-title":"Curr. Biol."},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b0900","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/emboj\/20.7.1692","article-title":"The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine","volume":"20","author":"Plun-Favreau","year":"2001","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0905","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cytogfr.2015.07.014","article-title":"Cardiotrophin-like cytokine factor 1 (CLCF1) and neuropoietin (NP) signalling and their roles in development, adulthood, cancer and degenerative disorders","volume":"26","author":"Sims","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0910","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/346120","article-title":"Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene","volume":"72","author":"Knappskog","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"26","key":"10.1016\/j.cyto.2021.155655_b0915","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1073\/pnas.0509598103","article-title":"Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient","volume":"103","author":"Rousseau","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0920","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ng0594-79","article-title":"A null mutation in the human CNTF gene is not causally related to neurological diseases","volume":"7","author":"Takahashi","year":"1994","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0925","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1354\/vp.08-VP-0239-B-BC","article-title":"Neonatal death in mice lacking cardiotrophin-like cytokine is associated with multifocal neuronal hypoplasia","volume":"46","author":"Zou","year":"2009","journal-title":"Vet. Pathol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0930","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0092-8674(95)90172-8","article-title":"Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth","volume":"83","author":"DeChiara","year":"1995","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b0935","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4049\/jimmunol.161.3.1371","article-title":"Cytokine-like factor-1, a novel soluble protein, shares homology with members of the cytokine type I receptor family","volume":"161","author":"Elson","year":"1998","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.cyto.2021.155655_b0940","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1523\/JNEUROSCI.23-26-08854.2003","article-title":"Cardiotrophin-like cytokine\/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo","volume":"23","author":"Forger","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0945","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S8756-3282(03)00116-9","article-title":"A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps","volume":"33","author":"Clancy","year":"2003","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0950","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bone.2009.01.367","article-title":"Joint loading-driven bone formation and signaling pathways predicted from genome-wide expression profiles","volume":"44","author":"Zhang","year":"2009","journal-title":"Bone"},{"issue":"32","key":"10.1016\/j.cyto.2021.155655_b0955","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1074\/jbc.AC119.008361","article-title":"Cardiotrophin-like cytokine (CLCF1) modulates mesenchymal stem cell osteoblastic differentiation","volume":"294","author":"Nahle","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0960","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.27200","article-title":"Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling","volume":"62","author":"Kalliolias","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b0965","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2011.02.022","article-title":"IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3","volume":"138","author":"Kamiya","year":"2011","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b0970","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1189\/jlb.3HI0616-280R","article-title":"Frontline Science: Human bone cells as a source of IL-27 under inflammatory conditions: role of TLRs and cytokines","volume":"101","author":"Larousserie","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b0975","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cytogfr.2012.10.001","article-title":"The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction","volume":"24","author":"Adamopoulos","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b0980","first-page":"411","article-title":"Humanin suppresses receptor activator of nuclear factor-\u03baB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation","volume":"23","author":"Kang","year":"2019","journal-title":"kjpp"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b0985","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2012.03622.x","article-title":"Interleukin-27 suppresses osteoclastogenesis via induction of interferon-gamma","volume":"137","author":"Park","year":"2012","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.cyto.2021.155655_b0990","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1074\/jbc.M116.764779","article-title":"Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene*","volume":"292","author":"Shukla","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155655_b0995","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17\u2013producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b1000","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.174.6.3534","article-title":"The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis","volume":"174","author":"Holscher","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.93.1.407","article-title":"Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders","volume":"93","author":"Yoshida","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.cyto.2021.155655_b1010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s12276-020-0445-6","article-title":"The JAK1\/STAT3\/SOCS3 axis in bone development, physiology, and pathology","volume":"52","author":"Sims","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b1015","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7157","key":"10.1016\/j.cyto.2021.155655_b1020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.cyto.2021.155655_b1025","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b1030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.194.2.189","article-title":"Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation","volume":"194","author":"Ernst","year":"2001","journal-title":"J. Exp. Med."},{"issue":"27","key":"10.1016\/j.cyto.2021.155655_b1035","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","volume":"274","author":"O'Brien","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cyto.2021.155655_b1040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nm763","article-title":"Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice","volume":"8","author":"Tebbutt","year":"2002","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1074-7613(00)80162-4","article-title":"Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses","volume":"12","author":"Ohtani","year":"2000","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cyto.2021.155655_b1050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nm1282","article-title":"Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling","volume":"11","author":"Jenkins","year":"2005","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b1055","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bone.2007.07.022","article-title":"Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice","volume":"41","author":"Yang","year":"2007","journal-title":"Bone"},{"issue":"9077","key":"10.1016\/j.cyto.2021.155655_b1060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b1065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b1070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jc.2014-3718","article-title":"Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis","volume":"100","author":"Leder","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.cyto.2021.155655_b1075","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1074\/jbc.271.18.10984","article-title":"Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction","volume":"271","author":"Greenfield","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155655_b1080","unstructured":"Zweifler, L.E., et al., Anabolic actions of PTH in murine models: Two decades of insights. Journal of Bone and Mineral Research. n\/a(n\/a)."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b1085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/JOE-14-0424","article-title":"gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation","volume":"223","author":"Standal","year":"2014","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b1090","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jcb.20506","article-title":"Effects of parathyroid hormone on Wnt signaling pathway in bone","volume":"95","author":"Kulkarni","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b1095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b1100","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b1105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S8756-3282(03)00202-3","article-title":"Anabolic and catabolic bone effects of human parathyroid hormone (1\u201334) are predicted by duration of hormone exposure","volume":"33","author":"Frolik","year":"2003","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.cyto.2021.155655_b1110","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","article-title":"Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo","volume":"60","author":"Axmann","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jcp.1041370125","article-title":"Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone","volume":"137","author":"Hattersley","year":"1988","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b1130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","article-title":"Osteoclast-derived activity in the coupling of bone formation to resorption","volume":"11","author":"Martin","year":"2005","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b1135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","article-title":"SOCS regulation of the JAK\/STAT signalling pathway","volume":"19","author":"Croker","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"issue":"23","key":"10.1016\/j.cyto.2021.155655_b1140","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1182\/blood-2009-11-253534","article-title":"Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs","volume":"116","author":"Winkler","year":"2010","journal-title":"Blood"},{"issue":"6882","key":"10.1016\/j.cyto.2021.155655_b1145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"issue":"1\u20133","key":"10.1016\/j.cyto.2021.155655_b1150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-5793(02)02889-2","article-title":"Leptin receptor isoform expression in rat osteoblasts and their functional analysis","volume":"528","author":"Lee","year":"2002","journal-title":"FEBS Lett."},{"issue":"24","key":"10.1016\/j.cyto.2021.155655_b1155","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1073\/pnas.95.24.14395","article-title":"Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1","volume":"95","author":"Starr","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b1160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00774-006-0685-0","article-title":"Osteoblast differentiation is impaired in SOCS-1-deficient mice","volume":"24","author":"Abe","year":"2006","journal-title":"J. Bone Miner. Metab."},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b1165","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/ni.2633","article-title":"The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation","volume":"14","author":"Yang","year":"2013","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b1170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0092-8674(00)80049-5","article-title":"SOCS3 is essential in the regulation of fetal liver erythropoiesis","volume":"98","author":"Marine","year":"1999","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cyto.2021.155655_b1175","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI25660","article-title":"SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis","volume":"116","author":"Wong","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1180","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41467-017-00920-x","article-title":"Bone corticalization requires local SOCS3 activity and is promoted by androgen action via interleukin-6","volume":"8","author":"Cho","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1185","first-page":"1","article-title":"The dynamics of bone structure development during pubertal growth","volume":"12","author":"Rauch","year":"2012","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.cyto.2021.155655_b1190","volume":"9","author":"Walker","year":"2020","journal-title":"Cortical bone consolidation requires local SOCS3-dependent suppression of osteoclasts through gp130\/STAT3 signalling in osteocytes eLife"},{"issue":"10","key":"10.1016\/j.cyto.2021.155655_b1195","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.joca.2019.05.018","article-title":"Deleting Suppressor of Cytokine Signaling-3 in chondrocytes reduces bone growth by disrupting mitogen-activated protein kinase signaling","volume":"27","author":"Liu","year":"2019","journal-title":"Osteoarthritis and Cartilage"},{"issue":"5","key":"10.1016\/j.cyto.2021.155655_b1200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00774-007-0766-8","article-title":"Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation","volume":"25","author":"Kamiya","year":"2007","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12860-016-0085-9","article-title":"Spatiotemporal patterns of sortilin and SorCS2 localization during organ development","volume":"17","author":"Boggild","year":"2016","journal-title":"BMC Cell Biology"},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcp.10151","article-title":"Sortilin is upregulated during osteoblastic differentiation of mesenchymal stem cells and promotes extracellular matrix mineralization","volume":"193","author":"Maeda","year":"2002","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-3782(00)00064-5","article-title":"The distribution of receptors for the pro-inflammatory cytokines interleukin (IL)-6 and IL-8 in the developing human fetus","volume":"58","author":"Dame","year":"2000","journal-title":"Early Hum Dev"},{"issue":"7","key":"10.1016\/j.cyto.2021.155655_b1220","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B","article-title":"Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown","volume":"44","author":"Rowan","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00223-009-9311-1","article-title":"Cytokine receptor-like factor 1 is highly expressed in damaged human knee osteoarthritic cartilage and involved in osteoarthritis downstream of TGF-beta","volume":"86","author":"Tsuritani","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1230","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S8756-3282(02)00806-2","article-title":"Expression of leukemia inhibitory factor (LIF)\/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF","volume":"31","author":"Liu","year":"2002","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.cyto.2021.155655_b1235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1242\/dev.122.2.419","article-title":"Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival","volume":"122","author":"Sheng","year":"1996","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.cyto.2021.155655_b1240","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ajpath.2014.11.008","article-title":"Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury","volume":"185","author":"Guihard","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155655_b1245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajhg.2007.09.002","article-title":"Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis","volume":"82","author":"Arita","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2021.155655_b1250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2006.07.001","article-title":"Cold-induced sweating syndrome A report of two cases and demonstration of genetic heterogeneity","volume":"250","author":"Hahn","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.cyto.2021.155655_b1255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/humu.22522","article-title":"Expanding the Mutational Spectrum of CRLF1 in Crisponi\/CISS1 Syndrome","volume":"35","author":"Piras","year":"2014","journal-title":"Hum. Mutat."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:04:51Z","timestamp":1760907891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":251,"alternative-id":["S1043466621002416"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155655","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influences of the IL-6 cytokine family on bone structure and function","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155655"}}